|
Volumn 36, Issue 4, 2000, Pages 767-774
|
Atrial natriuretic factor in oliguric acute renal failure
a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g |
Author keywords
Acute renal failure (ARF); Atrial natriuretic factor; Atrial natriuretic peptide (ANP)
|
Indexed keywords
ANARITIDE;
ATRIAL NATRIURETIC FACTOR;
PLACEBO;
ACUTE KIDNEY FAILURE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEMODIALYSIS;
HORMONAL THERAPY;
HUMAN;
HYPOTENSION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OLIGURIA;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
SYSTOLIC BLOOD PRESSURE;
|
EID: 0033810475
PISSN: 02726386
EISSN: None
Source Type: Journal
DOI: 10.1053/ajkd.2000.17659 Document Type: Article |
Times cited : (222)
|
References (22)
|